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In ReplyWhether slower reading contributes to Scantron fill-
ing speed is difficult to establish unless the same children are
assessed on both tasks, which as far as I know has not been
tested.While fillingScantron formsrequiresmotoractions that
reading does not, visual scanning is required to identify the
circled answers and locate the corresponding answerbubbles.
This engages oculomotor and visual skills in common with
reading (eg, saccades,1,2 accommodation, near vision). There-
fore, reading-associated factors may be associated with per-
formance on both tasks. The Brief Report by Kelly et al3 spe-
cifically states thatnoneof thechildrenwereenrolled inschool
reading intervention programs. If Drs Kelly and Birch believe
that Scantron filling is independent fromreading, then this ex-
clusion may not have been necessary.
Regardingmasking, I acknowledge thatmyphrasingat the
beginningofparagraph4ofmyInvitedCommentary4mayhave
been ambiguous, but the end of the same paragraph recom-
mends “careful masking of the study purpose from the par-
ticipants and the parents/caregivers, as well as masking the
participant’s visual status from the researchers collecting
data.”4(p942) Without further study, we can only guess at the
magnitude of any such psychosocial influences. In contrast
with what Drs Kelly and Birch stated in their Letter, I would
notpresume that theseunconscious influences canexplain all
of their results. As mentioned in my commentary,4 it is en-
tirely possible for some children to respond differently, add-
ing unnecessary variability.
Drs Kelly and Birchmay havemisreadmynext point. The
issue is not that the children’s habitual correctionswereused,
but rather that their report “does not state whether the cor-
rection was up-to-date or appropriate for their refractive
errors.”4(p942) Becauseno refractivedatawereprovided, read-
ers likemyself donotknowwhetheruncorrected refractive er-
rors may have been associated with the measured visuomo-
tor performance. The same issue also occurs in Drs Kelly and
Birch’s previous articles1,2 examining reading speed. In the so-
called realworld, prescribingpractices for older childrenwith
previous amblyopia can vary, and the lack of reported refrac-
tive informationmight limit theclinical interpretationandutil-
ity of results.
Intheoriginalmanuscriptsenttomeforcomment,DrsKelly
and Birch concluded the abstract by stating that childrenwith
abnormalbinocularvisionhistorymayrequireacademicaccom-
modations. This was amended in the final version, but I had
overlookedthechange. Inotehowever that thepublishedreport
still states that their findings“mayaid indevelopingnewguide-
lines in academic accommodations,”3(p940) and that aprevious
editorialbyDrsKellyandBirchappearstosupportsuchacademic
policies.5
Personally, I think academic accommodations can help
childrenwith substantial visual orvisuomotordeficits, if these
cannotbeamelioratedby treatments.Before jumping topolicy
recommendations,wemayalsoneed to reconcile current find-
ings with previous population-level evidence, which did not
showdefinitive andsubstantial associationsbetweenamblyo-
piaandacademic success.6Thismaybebecauseacademic suc-
cess ismultifactorial, requiringmore than just fast readingand
Scantron filling. I thank Drs Kelly and Birch for providing this
opportunity to clarify my comments.
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Implications of Birdshot-Like Uveitis
on the Pathogenesis of Birdshot Chorioretinopathy
To theEditorTherecentarticlebyAcaba-Berrocal et al1 presents
a case of birdshot-like chorioretinopathy in apatientwhowas
HLA-A29–negative and received treatmentwith a checkpoint-
blockade agent for malignant melanoma. This case is of con-
siderable interestwith implications for the immunopathogen-
esis of birdshot chorioretinopathy (BCR).
In most, if not all, patients with BCR, HLA-A29 is found;
however, HLA-A29 only confers risk, in that most white indi-
viduals who are HLA-A29–positive do not develop BCR. In-
creased risk is also conferred by killer-cell immunoglobulin-
like receptor genes and the HLA-B44 subtype that interacts
withkiller-cell immunoglobulin-like receptors,2 suggesting the
possibility of either an infectious or neoplastic trigger.We be-
lieve the inciting event may be the presence of skin cancers
orprecancerous lesions,whicharehighlyprevalent inmiddle-
aged white individuals, the population in which BCR is al-
most exclusively found. There is also a rare associationofBCR
with ocular melanoma, further supporting a role for neopla-
sia inciting the disease.3 In the case presented by Acaba-
Berrocal et al,1wepropose that immuneactivation through re-
lease of inhibition of the programmed cell death protein 1
checkpoint pathway in a patient treated for cutaneous mela-
noma mimics the altered immune reactivity to neoplastic
changes in the skin (whethermanifestormicroscopic) ina sub-
setof individualswhoareHLA-A29–positiveanddevelopBCR.
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Cancer immunosurveillancecould lead to initiationofBCR
throughantigenicmimicry involvingpresentationonHLA-A29
or loss of immunological tolerance. The situation is complex
and multifactorial, as evidenced by the rarity of BCR even in
middle-agedwhitepeople. For example, isolationofviralDNA
fromnonmelanoma skin cancers and their premalignant pre-
cursors suggests the potential of additional antigenic stimu-
lation from highly immunogenic viral epitopes in a system
adapted toward suppression of herpes-class viruses.4
While ithasbeensuggestedthatpatientswithBCRmayhave
ahigher incidenceof skincancers, thisassociationhasnotbeen
wellestablished.However, insomeindividuals, the incitingcan-
cersmaybesuccessfully suppressedoreliminatedby themobi-
lized immunesystem,resultingsecondarily in thedevelopment
ofBCRinanautoimmunity-promotingmilieu,withoutmanifes-
tationofclinicallydiagnosedskincancer.This iscongruentwith
recentobservationsthatwithcancer immunotherapy, thedevel-
opmentofuveitis andvitiligoas adverseeffects frequently sig-
nals successful tumor response.5
Theseobservationssupportourproposal that immunesur-
veillance and response to cutaneousneoplasia or ocularmela-
nomas may contribute to the development of BCR. This ex-
plains, at least in part, why BCR is nearly exclusively found in
middle-aged and older white individuals.
Michel M. Sun, MD, PhD
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In ReplyWe readwith interest the letter from Sun et al regard-
ing possible pathophysiologic implications of our article on
birdshot-like chorioretinopathy associated with pembroli-
zumab treatment.1 In the article,we observed a single patient
whowas treated for cutaneousmelanomawith a checkpoint-
inhibitor agent directed against the programmed cell death-1
receptor on T cells and soon thereafter developed a classic-
appearing case of birdshot chorioretinopathy (BCR) in both
eyes. Testing for HLA-A29 was negative. We speculated that
this immunotherapywas associatedwith thedevelopment of
clinical features of BCR.
Basedonthiscase,Sunetalproposedadetailed theory that
“immune surveillance and response to cutaneousneoplasia or
ocularmelanomasmaycontribute to thedevelopmentofBCR.”
Wewerenotawareof this association.Lookingbackoverour31
yearsofexperienceinabusyocularoncologypractice,whichhas
involved treating several thousand patients with uveal mela-
noma, therehasbeennopatientwhoclinicallymanifestedBCR.
Further, theassociationwithcutaneousmelanomahasnotbeen
verified.APubMedsearch for “cutaneousmelanomaandbird-
shot”yieldednoreports.However,weagreewiththeauthorsthat
immunesurveillance likelyplays a role inBCR. In this case, the
immunotherapycheckpoint inhibitorunleashedandactivated
T cells, which likely led to the development of this immune-
mediated condition. The exact cascade of events remains un-
known, to our knowledge.
Althoughmany of the uveitides remain idiopathic or un-
differentiated,we should always strive to find the underlying
causeor causes.Forexample, tattoo-associateduveitis is a rare
form of uveitis with clinical features that can mimic sarcoid-
osis. Whether tattoo-associated uveitis represents a distinct
entity or a subset of cutaneous sarcoidosis remains unclear.2
It is possible that themorphologyof someof theuveitidesmay
represent a final common pathway in the ocular inflamma-
tory cascade, so that similar clinical findings may have mul-
tiple causes, including genetic predispositions and environ-
mental exposure.
Understanding of the pathophysiology of BCR is limited
by the rarity of the disease, paucity of histopathologic speci-
mens, inconsistent descriptions of findings, limited under-
standing of genetic factors, and sometimes conflicting case
definitions. The association of BCR with melanoma, as de-
scribed by Pulido et al,3 and the hypothesis of Sun et al that
immune surveillance and response to cutaneous neoplasia or
ocularmelanomasmay contribute to thedevelopment of BCR
(which helps to explain why BCR is almost always found in
white individualswho aremiddle-aged andolder, rather than
others) represent tantalizing clues towardunraveling themys-
teries of this disease. Perhaps big data, such as that of the
American Academy of Ophthalmology’s Intelligent Research
in Sight registry and the French national registry for rare dis-
eases, byusing feature-based rather thandiagnosis-baseddata
sets,will provideconfirmationof thehypothesisof Sunetal.4,5
We appreciate their interest in our findings and look forward
to hearing more from their future research.
James P. Dunn, MD
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Carol L. Shields, MD
Author Affiliations: The Retina Service, Wills Eye Hospital, Thomas Jefferson
University, Philadelphia, Pennsylvania (Dunn); Ocular Oncology Service,
Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
(Acaba-Berrocal, Shields).
Corresponding Author: Carol L. Shields, MD, Ocular Oncology Service,
Wills Eye Hospital, 840Walnut St, Ste 1440, Philadelphia, PA 19107
(carolshields@gmail.com).
Published Online:March 14, 2019. doi:10.1001/jamaophthalmol.2019.0220
Letters
584 JAMAOphthalmology May 2019 Volume 137, Number 5 (Reprinted) jamaophthalmology.com
© 2019 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a University of California - Los Angeles User  on 06/03/2019
Conflict of Interest Disclosures:Dr Dunn reports personal fees from AbbVie
Inc outside the submitted work. No other disclosures were reported.
1. Acaba-Berrocal LA, Lucio-Alvarez JA,MashayekhiA,HoAC,Dunn JP, ShieldsCL.
Birdshot-like chorioretinopathy associatedwithpembrolizumab treatment. JAMA
Ophthalmol. 2018;136(10):1205-1207. doi:10.1001/jamaophthalmol.2018.1851
2. Reddy AK, Shildkrot Y, Newman SA, Thorne JE. T-lymphocyte predominance
and cellular atypia in tattoo-associated uveitis. JAMA Ophthalmol. 2015;133(11):
1356-1357. doi:10.1001/jamaophthalmol.2015.3354
3. Pulido JS, Canal I, Salomão D, Kravitz D, Bradley E, Vile R. Histological
findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma.
Eye (Lond). 2012;26(6):862-865. doi:10.1038/eye.2012.10
4. Lee CS, Lee AY, Holland GN, Van Gelder RN, Tufail A. Big data and uveitis.
Ophthalmology. 2016;123(11):2273-2275. doi:10.1016/j.ophtha.2016.08.037
5. Choquet R, Maaroufi M, de Carrara A, Messiaen C, Luigi E, Landais P.
Amethodology for a minimum data set for rare diseases to support national
centers of excellence for healthcare and research. J AmMed Inform Assoc. 2015;
22(1):76-85. doi:10.1136/amiajnl-2014-002794
Association of Cataract Surgery
With Driving Safety and Falls
To the Editor Cataracts are a leading cause of reversible
vision impairment worldwide, and age-associated decline in
visual acuity has been associated with increased risk for
car crashes and falls.1 A recent, methodologically strong,
population-based study2 has found that the rate of serious
car crashes decreased by 9% after cataract surgery. The
researchers2 evaluated 559 546 patients who had cataract
surgery in at least 1 eye. The association between cataract
surgery and crash involvement has been previously reported
by Owsley et al.1 This study found that patients with cataract
who underwent cataract surgery experienced only half the
crash risk compared with patients with similar conditions
who did not undergo surgery. An Australian study3 based on
similar linked administrative data also found cataract sur-
gery is effective in reducing car crashes. The reduction in
crash risk associated with cataract surgery lends support for
consideration of cataract surgery prioritization for drivers
older than 65 years.
However, poor vision is only 1 ofmany risk factors formo-
tor vehicle crashes and falls.4 Other potential risk factors in-
clude visual processing speed, multiple comorbidities, poly-
druguse, cognitive status changes, reducedcognitivecapacity,
balance and gait impairments, functional impairments, and
changes in neuromuscular function, motor function, reac-
tion time, hearing, and physical activity levels.3-5 Unfortu-
nately, itwas impossible to examine these factors throughad-
ministrative health data sets. Even though the benefit of a
population-based approach is that the crash involvement can
be investigated with a sufficient sample size, a limitation of
the current study2 is that information gleaned from anony-
mous recordsdoesnot extend far beyond the recordingof sur-
geries, car crashes, and falls.Theauthors2mentionedthatcata-
ract surgery was not associated with a reduction in the
subsequent risks of falls. Other important factors that might
be useful to include and influence interpretation of the re-
sultswouldbe thenumberof timesaparticipanthad fallenbe-
fore the cataract surgery, since a previous fall is a known risk
factor for recurrent falls. This information is not likely avail-
able in thisdata set.Therefore, itmaybebeneficial for theoph-
thalmology research community to think innovatively how
these other individual patient–level data might be incorpo-
rated successfully into population-based data sets, to further
the understanding of the association of cataract surgerywith
motor vehicle crash involvement by older adults.
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In ReplyWe thankDr Desapriya for the letter regarding our ar-
ticle, “Association of Cataract SurgeryWith Traffic Crashes.”1
Weagree in thevalueofpopulation-basedresearch inproviding
a comprehensive, longitudinal, patient-level, self-matched
analysis of important clinical outcomes, suchas traffic crashes
and falls. We also agree that many factors beyond impaired
vision can contribute to adverse incidents and cataract sur-
gery can only improve vision, contrast sensitivity, and glare,
but not other factors that contribute to these incidents.2
The results also indicate that cataract surgery does not com-
pletely eliminate the risk of a traffic crash or fall.
We agree that limitations of administrative database re-
search include a lack of detailed clinical information. In addi-
tion,administrativedatabase researchofemergencyvisitsdoes
not addressnear-miss eventsor fatal events. The reported sec-
ondary analysis of falls does not preclude visual impairment
as a potential risk factor, and we acknowledge that more re-
search isneededonapotential association.3-5Oneof the stron-
gest risk factors for traffic crasheswas aprevious traffic crash;
wedidnot formallyevaluate risk factors for the secondaryout-
comes, although we would also presume that a previous fall
is a risk factor for subsequent falls. We hope that continued
research into important adverse events, in linewithourmedi-
cal research into drug toxicity and surgical complications,
might help elucidate risk factors and preventive strategies to
ultimately improve patient lives.
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